Five reasons to use IBM Micromedex NeoFax and Pediatrics
Ensures the highest levels of drug safety
Infants and children are an especially vulnerable patient population, particularly regarding medication safety. IBM Micromedex NeoFax and Pediatrics addresses the unique needs of these patients to enable clinicians to make safer, more informed decisions about their medications.
Delivers population-specific drug information
The monographs are focused specifically on neonatal or pediatric drug therapy. The content is evidence-based, fully referenced, off-label focused and designed to allow clinicians quick and reliable access to only the most population-specific information. The patient populations of both IBM Micromedex NeoFax and IBM Micromedex Pediatrics are available within the same interface, providing one source of relevant drug knowledge – from the most premature neonate, up to age 18.
Provides age- and indication-specific dosing calculators
The solution includes dosing calculators for every drug in the individual solutions. These age- and indication-specific calculators are prepopulated with evidence-based recommendations that address dose, concentration and administration. This powerful clinical decision support functionality provides clinicians with the dosage options for each patient quickly. It also provides warning messages for out-of-range values, working to significantly decrease the risk for dosing errors.
Enhances enteral nutrition support
The enteral formula database within IBM Micromedex NeoFax and Pediatrics is an additional resource to support the nutritional health and well-being of neonatal and pediatric patients. With important information about infant formula and human milk fortifiers, this feature allows for comparison of multiple products to facilitate selection of the most appropriate nutritional support product.
Provides peace of mind when it matters most
IBM Micromedex NeoFax and Pediatrics builds on the 30-plus-year reputation of Micromedex NeoFax as one of the leading neonatal drug information resources. The neonatal and pediatric content is created using the comprehensive editorial processes and clinical rigor of IBM Micromedex, providing evidence-based information based on the best available population-specific published literature.